维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="LIAWYF"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Faminial risk of hepatocelluarear cinoma among chronic hepatitis B carriers and their relatives显示文摘	Yu M W Chang H C LiawYF	2000	J Natl Cancer Inst2000，92，14：	1
2	No benefit to continue lamivudine therapy after emergence of YMDD mutations显示文摘	LiawYF Chien RN Yeh CT	2004	Antivir Ther2004，9，：	1
3	Lamivudine for patientswith chronic hepatitis B and advanced liver disease显示文摘	LiawYF Sung JJ Chow WC	2004	NEngl J Med2004，351，15：	1
4	Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy显示文摘	Chien RN Yeh CT	1999	Hepatology1999，30，2：	1
5	Two years lamivudine therapy in chronic hepatitis B infection:results of a placebo-controlled multicentre study in Asia 显示文摘	LiawYF Lai CL Leung NWY	1998	Gastroenterol1998，114，2：	1
6	Telbivudine improves renal function in patients with chronic hepatitis B显示文摘	Gane EJ Deray G LiawYF	2014	Gastroen- terology2014，141，1：	1
7	Effects oflamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prosective double-blind placebo controlled trial 显示文摘	LiawYF Sung J J ChowWC etal	2003	Hepatology2003，，：	1
8	Prevention and surveillance of hepatitis B virus- related hepatocellular carcinoma显示文摘	LiawYF	2005	Semin Liver Dis2005，，：	1
9	Asian - Pacific consensusstatement on the management of chronic hepatitis B: a 2008update显示文摘	LiawYF Leung N Kao JH	2008	Hepatol Int2008，2，3：	1
10	Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection:hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis显示文摘	Chu CM LiawYF		Gastroenterology0，，：	1
11	2-Year GLOBE trial results telbivudine issuperior to lamivudine in patients with chronic hepatitis B 显示文摘	LiawYF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
12	Asian–Pacific consensus statement on the management of CHB: a 2008 update显示文摘	LiawYF LeungN KaoJH	2008	Hepatol Int2008，2，26：	1
13	Shorter durations and lower doses of peginterferonalfa–2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C显示文摘	LiawYF JiaJD ChangHL	2011	Hepatology2011，54，15：	1
14	Long–term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B显示文摘	ChangTT LiawYF WuSS	2010	Hepatology2010，52，88：	1
15	HepatitisBvirusinfection显示文摘	LiawYF ChuCM	2009	Lancet2009，373，9663：	1
16	Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease显示文摘	LiawYF SheenIS LeeCM	2011	Hepatology2011，53，1：	1
17	Effects of lamivudint on disease progression and development of liver cancer in advanced chronic hepatitisB: a prospective double - blined placebo - controlled clinica trial 显示文摘	LiawYF Sung JJY Chow WC	2003	Hepatology2003，38，1：	1
18	Hepatitis Beantigen andthe risk of hepatoceUular Carcinoma显示文摘	YangHI LuSN LiawYF etal	2002	NEnglJMed2002，347，：	1
19	Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus 显示文摘	CHUCM YEHCT LIAWYF	1999	Gut1999，45，：	1
20	Lamivudine for patients with chronic hepatitis b and advanced liver disease显示文摘	LiawYF Sung JJY Chow WC	2004	N Engl J Med2004，351，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示